Vice President, Business Development, Search & Evaluation

Overview

Who We Are Teva is a global pharmaceutical leader and the world's largest generic medicines producer, committed to improving health and increasing access to quality health solutions worldwide. Our employees are at the core of our success, with colleagues in over 80 countries delivering the world's largest medicine cabinet to 200 million people every day. We offer a uniquely diverse portfolio of products and solutions for patients, and we've built a promising pipeline centred around our core therapeutic areas which include neuroscience, immunology, and immuno-oncology.

We are continually developing patient-centric solutions and significantly growing both our generic, biosimilar, and innovative medicines business through investment in research and development, marketing, business development and innovation. This is how we improve health and enable people to live better, healthier lives. Join us on our journey of growth!

The Opportunity We are seeking a dynamic and visionary Vice President of Search and Initial Evaluation to spearhead strategic growth initiatives, with a focus on identifying, assessing, and securing external partnerships and opportunities within the pharmaceutical landscape. This pivotal role will drive the expansion of our presence across early-stage drug discovery and mid- to late-stage development, particularly in target identification, evaluation, and screening technologies.

As a senior leader, this individual will be instrumental in advancing our mission to deliver innovative therapies across CNS, immunology and inflammatory diseases (I&I), and rare diseases. The ideal candidate will possess a strong scientific background, a robust industry network, and a proven ability to uncover high-value opportunities that align with our R&D and commercial objectives.

This is a high-impact position for a strategic thinker who thrives in a fast-paced, agile environment and who blends scientific rigor with creative foresight. The successful candidate will lead the sourcing, initial assessment, and early diligence of external assets and technology platforms—helping to shape the company's future trajectory and unlock its next wave of growth.

• Proactively identify and assess external innovation opportunities (e.g., assets, platforms, technologies) in core therapeutic areas: CNS, I&I diseases, and rare diseases aligned to Teva’s Pivot to Growth strategy.
• Significantly increase the volume and breadth of sourced opportunities, while ensuring alignment with the company’s strategic and scientific priorities—improving the quality and quantity of assets that progress to advanced evaluation and potential deal discussions.
• Build and maintain deep relationships across the biotech and pharmaceutical ecosystem, including with academic institutions, investors, incubators, and early-stage companies.
• Collaborate closely with internal stakeholders (R&D, commercial, legal, finance) to perform scientific, strategic, and commercial assessments of potential external opportunities.
• Build and manage a high-performing, business development search team, with strong scientific foundations fostering a culture of innovation and accountability.
• Lead the initial due diligence process for high-priority opportunities, including data review, competitive landscaping, and risk/benefit analysis.
• Strategically represent the company externally at scientific and business development conferences, staying abreast of relevant innovation and competitive activity.
• Contribute to the development of partnership and licensing strategies, including co-development and co-commercialization opportunities.

• Lead, manage, and develop a high-performing Search & Initial Evaluation team, ensuring strong execution, consistent quality, and broad coverage of external innovation.
• Set priorities, allocate resources, and guide team members in identifying, evaluating, and presenting external opportunities.
• Establish best practices for opportunity triage, cross-functional collaboration, and documentation of scientific and strategic rationale.

• Ph.D., M.D., or advanced degree in life…